i

ikarovec

6 employees

Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
ocular hypertension
geographic atrophy
wet age-related macular degeneration
gene therapy
ophthalmology
Life Science
diabetic macular edema (DME)

Date founded

2018

Funding rounds raised

Total raised

$3.3M

from 2 investors over 2 rounds

i

ikarovec raised $3.3M on February 5, 2020

Investors: UK Innovation & Science Seed Fund and Parkwalk Advisors

FAQ